Search results for: '9ab9'

Despite the term patient centricity gaining currency in the industry, there is a degree of variability in a companies’ approach and strategic priorities. Frost & Sullivan sees digitization playing a critical role in transforming the clinical trial model from traditional, high-cost, and difficult-to-access centralized settings to more patient-centri...

Artificial intelligence (AI) is exhibiting real promise across multiple industries. The healthcare industry is leading the charge when it comes to focused AI application development and attracting AI investment globally. With improvements in healthcare data acquisition and computing power, AI is becoming more of a reality each day. Frost & Sullivan...

This research insight aims to provide an analysis of healthcare infrastructure and the procedural volume of using ultrasound, in the global market in 2018. Ultrasound machines are becoming lighter, more portable, and compact due to advances in a number of areas of technology (e.g., scan mode, image retrieval, and operation system) and especially b...

Technology and design improvements in multipurpose R/F Systems, the recent increase in the adoption of fluoroscopy procedures by private healthcare facilities and commercialization of disruptive technologies in real-time R/F are set to boost growth opportunities in the Western European fluoroscopy market. These multi-functional R/F systems have the...

This study examines the Turkish medical imaging market. Healthcare reforms focusing on oncology and cardiology as the priority areas has resulted in 80% of medical imaging equipment being purchased by the government. Frost & Sullivan estimates that revenue for computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound (USG) will rea...

This report aims to highlight the potential of Israel in becoming one of the leading centres for digital health innovation, globally. The report also presents some of the innovative startups working in the digital health space, as an example of the country’s potential.--BEGIN PROMO--Research Scope Market  trends (emission regulations/mandat...

The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...